Every year, cancer specialists from around the world gather at the American Society of Clinical Oncology (ASCO) Annual Meeting to share the latest advances in cancer research and treatment. While many of the presentations are highly scientific, the overall message from ASCO 2026 was encouraging: cancer care continues to become more personalized, more precise, and more effective. Here are five exciting developments that caught our attention this year. 1. A New Targeted Therapy

A new study from the Community Oncology Alliance (COA) shows that patients treated in community oncology settings—like St. Louis Cancer Care—may experience longer survival compared to national benchmarks. Researchers analyzed data from nearly 98,000 patients with metastatic breast cancer and metastatic non-small cell lung cancer and compared outcomes to the National Cancer Institute’s SEER database. The results were encouraging. Patients with metastatic breast cancer lived up

Dr. Giancarlo Pillot recently attended the Community Oncology Alliance (COA) Conference, joining oncology leaders from across the country to discuss the latest advancements in cancer care. The annual COA conference focuses on innovation in practice, advocacy for community oncology, and strategies to improve patient outcomes close to home. At St. Louis Cancer Care, we are committed to staying at the forefront of oncology care. By engaging with national organizations like COA,

If you or a loved one has been diagnosed with cancer, you may hear your care team mention “genetic testing.” For many patients, this can feel confusing or even overwhelming. What does it mean? Why is it important? And how does it affect your treatment? Let’s break it down in a simple, practical way. What is genetic testing in cancer? Genetic testing looks at the DNA involved in cancer to help guide treatment decisions. There are two main types of genetic testing, and understa